Roche expertise helped Merck:
Merck & Co. Inc. turned to Roche Diagnostics, which has its North American headquarters in Indianapolis, to help it win regulatory approval in October for its new HIV drug, Isentress. New Jersey-based Merck tested patients during clinical trials with Roche Diagnostics’ viral-load test, called COBAS HIV-1 AMPLICOR. Roche’s HIV-1 viral-load test has been the predominant choice in HIV anti-retroviral clinical drug trials since 1996. Merck’s new drug is an integrase inhibitor, which prevents replication of HIV by blocking insertion of…